Is Quest Diagnostics (DGX) A Great Investment Choice?
Davis Funds, an investment management firm, published its “Davis Opportunity Fund” fourth-quarter 2021 investor letter – a copy of which can be downloaded here.
Quest Diagnostics Inc (DGX)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,131,900 | $154,912 | -15% | 0.18% |
| 2. | AQR Capital Management Cliff Asness | 777,718 | $106,438 | -1% | 0.2% |
| 3. | Millennium Management Israel Englander | 257,914 | $35,298 | +312% | 0.01% |
| 4. | 184,200 | $25,210 | 0.85% | ||
| 5. | 181,200 | $24,799 | +78% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.51 | 4,000 | Officer | 44,222 | 2014-05-05 | Filing | |
| $50.71 | 2,600 | Director | 5,658 | 2014-02-06 | Filing | |
| $50.70 | 2,400 | Director | 3,058 | 2014-02-06 | Filing | |
| $59.34 | 5,000 | Officer, Director | 68,034 | 2012-08-07 | Filing | |
| $56.89 | 20,000 | Officer, Director | 63,034 | 2012-05-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $142.13 | 900 | Officer, Director | 334,833 | 2022-05-25 | Filing | |
| $141.35 | 4,131 | Officer, Director | 335,733 | 2022-05-25 | Filing | |
| $140.58 | 9,823 | Officer, Director | 339,864 | 2022-05-25 | Filing | |
| $142.15 | 651 | Officer, Director | 334,833 | 2022-05-25 | Filing | |
| $141.36 | 2,565 | Officer, Director | 335,484 | 2022-05-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 811,574 | $111,072,017 | 0.04% | |
| 2. | 156,576 | $21,428,991 | 0.02% | |
| 3. | 83,048 | $11,365,949 | 0.06% | |
| 4. | 40,000 | $5,474,400 | 0.04% | |
| 5. | 35,234 | $4,822,125 | 0.06% |
News See All
How Did Hedge Funds’ Quest Diagnostics Incorporated (DGX) Bets Fare?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
5 Value Stocks to Buy According to Billionaire Paul Tudor Jones
In this article, we discuss the 5 value stocks to buy according to billionaire Paul Tudor Jones.
Is Quest Diagnostics Incorporated (DGX) A Good Stock To Buy?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Here’s Why Davis Funds Became Bullish Quest Diagnostics (DGX)
Davis Funds, an investment management firm, published its “Davis Opportunity Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Dumping Quest Diagnostics Incorporated (DGX)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Should You Consider Investing in Quest Diagnostics (DGX)?
Heartland Advisors, an investment management firm, published its "Heartland Mid Cap Value Fund" second-quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Aren’t Crazy About Quest Diagnostics Incorporated (DGX) Anymore
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Best Undervalued Stocks to Buy Now
The COVID-19 pandemic has brought about an unexpected turn of events with many equities now trading at a lower price than their intrinsic value.
10 Best Undervalued Dividend Stocks to Buy Now
In this article, we will take a look at the 10 best undervalued dividend stocks to buy now.
Billionaire Hedge Funds
